NCT06875947
EFFECTS of MICRONIZED MORINGA OLEIFERA LEAF POWDER on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 7 words Show 7 more changesShow less
- Trial completed
- Interventions modified
- Secondary endpoints: details revised at 12 of 16 entries
- Study description expanded, about 213 words
- Study site revised
- Publications: details revised at 5 of 5 entries
- Study title expanded, about 1 word
- Notable Changed Sponsor changed: Fakultas Kedokteran Universitas Padjadjaran to Universitas Padjadjaran
Notable Primary endpoints: 8 to 1v7 Show 7 more changesShow less
- Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 72 to confirmed 59
- Primary completion date: Mar 31, 2026 to Apr 30, 2026
- Study completion date: Apr 30, 2026 to May 31, 2026
- Secondary endpoints: 9 to 16
- Site details revised
- Study description expanded, about 1 word
Notable Phase: Phase 4 to Not applicablev6 Show 7 more changesShow less
- Trial status: Not Yet Recruiting to Recruiting
- Primary completion date: Sep 2025 to Mar 31, 2026
- Study completion date: Oct 2025 to Apr 30, 2026
- Start date changed from estimate of Apr 2025 to May 23, 2025
- Interventions: Moringa Oleifera Leaf Micronized Powders in Capsule (Dietary Supplement), Standard Iron Tablets (Fe + Folic Acid) (Dietary Supplement) to Moringa Oleifera Leaf Micronized Powders in Capsule (Dietary Supplement), Standard Iron Tablets (Fe + Folic Acid) (Drug)
- Study description expanded, about 69 words
- Site details revised
- Notable Primary endpoints: 7 to 8v5
Show 3 earlier versionsHide 3 earlier versions
- Minor Study sites: 0 to 1
- Start date: Mar 2025 to Apr 2025
- Study title revised
- Study description expanded, about 1 word
- Minor Study title shortened, about 11 wordsv3
- Minor Interventions: Moringa Oleifera Leaf Micronized Powders in Capsule (Dietary Supplement) to Moringa Oleifera Leaf Micronized Powders in Capsule (Dietary Supplement), Standard Iron Tablets (Fe + Folic Acid) (Dietary Supplement)v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (16)
Show 11 moreShow less
Arms and interventions
Participants in this group will receive Micronized Moringa Oleifera Leaf Powder (MMOLP) 3×650 mg/day in capsule form, combined with standard iron tablets (Fe tablet 60 mg + Folic Acid 400 mcg/day) for 60 days. This intervention aims to evaluate the combined effect of Moringa Oleifera and standard iron supplements on hematological parameters, iron homeostasis, and inflammatory markers in pregnant women with iron deficiency anemia.
Participants in this group will receive only standard iron tablets (Fe tablet 60 mg + Folic Acid 400 mcg/day) for 60 days. This arm serves as the control group to compare the effectiveness of standard iron therapy alone versus the combined intervention (MMOLP + Iron Tablets).
Dietary supplements: Micronized Moringa Oleifera Leaf Powder in Capsule
Drugs: Standard Iron Tablets (Fe + Folic Acid)
Sites
1 site in 1 country
- PUSKESMAS: 1. Muka 2. Karangtengah 3. Cijedil 4. Cianjur Kota 5. Nagrak 6. Warungkondang 7. Cibeber 8. Cilaku 9. Gekbrong 10.Ciherang 11.Ciranjang 12. Cugenang 13.Sukaluyu 14. Kademangan 15. Mande 16. CibaregbegCianjur, West Java, Indonesia